Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cvitkovic

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
British Journal of Cancer|February 1, 1996
Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysisF Janot, J Klijanienko, A Russo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1993
Phase II study of cisplatin and 120-hour continuous infusion of 5-fluorouracil in patients with advanced pancreatic adenocarcinomaP Rougier, J J Zarba, M Ducreux, et al.
Cancer|August 15, 1981
VAB-3 combination chemotherapy of metastatic testicular cancerT F Reynolds, D Vugrin, E Cvitkovic, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
Factors predicting for efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU)+/-folinic acid (FA) in a compassionate-use cohort of 370 5-FU-resistant advanced colorectal cancer (CRC) patientsBensmaïne, A de Gramont, S Brienza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal typeA Hasbini, R Mahjoubi, A Fandi, et al.
Cancer|April 1, 1995
Tumor vascularization, mitotic index, histopathologic grade, and DNA ploidy in the assessment of 114 head and neck squamous cell carcinomasJ Klijanienko, A K el-Naggar, F de Braud, et al.
British Journal of Cancer|July 20, 2007
Antiproliferative effects of sapacitabine (CYC682), a novel 2'-deoxycytidine-derivative, in human cancer cellsM Serova, C M Galmarini, A Ghoul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Ecteinascidin-743: a marine-derived compound in advanced, pretreated sarcoma patients--preliminary evidence of activityS Delaloge, A Yovine, A Taamma, et al.
British Journal of Cancer|November 27, 2008
Antiproliferative activity of PEP005, a novel ingenol angelate that modulates PKC functions, alone and in combination with cytotoxic agents in human colon cancer cellsK A Benhadji, M Serova, A Ghoul, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1997
Cumulative pharmacokinetic study of oxaliplatin, administered every three weeks, combined with 5-fluorouracil in colorectal cancer patientsE Gamelin, A L Bouil, M Boisdron-Celle, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
British Journal of Cancer|February 1, 1996
Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysisF Janot, J Klijanienko, A Russo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1993
Phase II study of cisplatin and 120-hour continuous infusion of 5-fluorouracil in patients with advanced pancreatic adenocarcinomaP Rougier, J J Zarba, M Ducreux, et al.
Cancer|August 15, 1981
VAB-3 combination chemotherapy of metastatic testicular cancerT F Reynolds, D Vugrin, E Cvitkovic, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
Factors predicting for efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU)+/-folinic acid (FA) in a compassionate-use cohort of 370 5-FU-resistant advanced colorectal cancer (CRC) patientsBensmaïne, A de Gramont, S Brienza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal typeA Hasbini, R Mahjoubi, A Fandi, et al.
Cancer|April 1, 1995
Tumor vascularization, mitotic index, histopathologic grade, and DNA ploidy in the assessment of 114 head and neck squamous cell carcinomasJ Klijanienko, A K el-Naggar, F de Braud, et al.
British Journal of Cancer|July 20, 2007
Antiproliferative effects of sapacitabine (CYC682), a novel 2'-deoxycytidine-derivative, in human cancer cellsM Serova, C M Galmarini, A Ghoul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Ecteinascidin-743: a marine-derived compound in advanced, pretreated sarcoma patients--preliminary evidence of activityS Delaloge, A Yovine, A Taamma, et al.
British Journal of Cancer|November 27, 2008
Antiproliferative activity of PEP005, a novel ingenol angelate that modulates PKC functions, alone and in combination with cytotoxic agents in human colon cancer cellsK A Benhadji, M Serova, A Ghoul, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1997
Cumulative pharmacokinetic study of oxaliplatin, administered every three weeks, combined with 5-fluorouracil in colorectal cancer patientsE Gamelin, A L Bouil, M Boisdron-Celle, et al.
Pageof 13